West Pharmaceutical Services Inc. 

(Public, NYSE:WST)   Watch this stock   
Find more results for WST
Nov 17, 2009
Lazard Capital Healthcare Conference
Nov 3, 2009
Q3 2009 Earnings Conference Call - Webcast
Nov 3, 2009
Q3 2009 Earnings Release
Sep 23, 2009
UBS Global Life Sciences Conference
Sep 17, 2009
CL King and Associates Best Ideas Conference - Webcast
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin 6.33% 8.16%
Operating margin 10.00% 11.81%
EBITD margin - 17.63%
Return on average assets 5.30% 7.29%
Return on average equity 12.56% 17.69%
Employees 6,300 -

Address

101 Gordon Drive PO Box 645
Lionville, PA 19341-0645
United States - Map
+1-610-5943319 (Phone)
+1-610-5943000 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

West Pharmaceutical Services Inc. discussed on blogs

Ranking 1300+ Small Cap Stocks by Cash Flow Per Share - NASD100 ... - Investor's Resources - NASD100.com - Daily Stock Rankings - 3 hours ago
Mike Havrilla on NVO - NovoNordisk A/S - SocialPicks - Mike Havrilla - SocialPicks.com: Recent Picks - 14 hours ago

West Pharmaceutical Services Inc. discussions

  View all discussions »

Description

West Pharmaceutical Services, Inc. (West) is a manufacturer of components and systems for injectable drug delivery and plastic packaging and delivery system components for the healthcare, personal care and consumer products markets. Its products include stoppers and seals for vials and components used in syringe, intravenous and blood collection systems. The Company’s customers include pharmaceutical, biotechnology, generic drug and medical device producers. West operates in two segments: Pharmaceutical Systems and Tech Group. The Pharmaceutical Systems segment designs, manufactures and sells a variety of elastomer, metal and plastic components used in parenteral drug delivery for the branded pharmaceutical, generic and biopharmaceutical industries and generic industries. Its Tech Group segment is a custom injection molder.

Officers and directors

Donald E. Morel Jr., Ph.D.
Chairman of the Board, Chief Executive Officer
Age: 51
Bio & Compensation - Reuters
Steven A. Ellers
President
Age: 58
Bio & Compensation - Reuters
William J. Federici
Chief Financial Officer, Vice President
Age: 49
Bio & Compensation - Reuters
Robert S. Hargesheimer
President - Tech Group
Age: 51
Bio & Compensation - Reuters
Donald A. McMillan
President, Americas - Pharmaceutical Systems Division
Age: 50
Bio & Compensation - Reuters
Fabio De Sampaio Dorio Filho
President - Pharmaceutical Systems Division, Europe and Asia Pacific
Age: 45
Bio & Compensation - Reuters
Matthew T. Mullarkey
Chief Operating Officer
Age: 46
Bio & Compensation - Reuters
John R. Gailey III
Vice President, General Counsel, Secretary
Age: 54
Bio & Compensation - Reuters
Michael A. Anderson
Vice President, Treasurer
Age: 53
Bio & Compensation - Reuters
Joseph E. Abbott
Vice President, Corporate Controller
Age: 56
Bio & Compensation - Reuters